Cytochrome P450 (CYP)-epoxygenase is highly expressed in the kidney and its metabolism of arachidonic acid plays important roles in regulating renal Na transport and in modulating vasoactivity in the kidney. In the past several years, progress has been made not only in characterizing the specific CYP-epoxygenases responsible for the regulation of membrane transport and vasoactivity in the kidney but also in exploring the mechanism by which they regulate renal Na transport and vasodilation of preglomerular arterioles. This review summarizes and updates recent progress in this area of research.
INTRODUCTION
Cytochrome P450s (CYP) belong to a gene superfamily whose members share a conserved cysteinyl peptide that provides for heme ligation and endows them with unique catalytic properties [1] . On the basis of amino acid sequence identity, P450s are organized into families (!40% identity) and subfamilies (!55% identity), with approximately 57 genes identified in the human genome. In addition to their established roles in drug and xenobiotic metabolism [1] , the 'P450 arachidonic acid monooxygenase' branch of the arachidonic acid metabolic cascade [2] [3] [4] [5] catalyzes the NADPHdependent oxidation of arachidonic acid to four regioisomeric epoxyeicosatrienoic acids (EETs) (5, 6, 8, 9, 11, 12 and 14, [5] ('arachidonic acid epoxygenase'), and/or to 19 and 20-hydroxyeicosatetraenoic acids (19 and 20-HETE) [5] ('arachidonic acid v/v-1 hydroxylase') ( Fig. 1) . In most cells and organ tissues, the EETs can be hydrated to vic-dihydroxyeicosatrienoic acids (DHETs) by cytosolic epoxide hydrolase, and degraded by b-oxidation, or acylated into cellular glycerophosopholipids [2] [3] [4] [5] . The identification of EETs and 20-HETE as products of the in-vivo metabolism of arachidonic acid by rodent and human tissues [5] established the arachidonic acid monooxygenase as a formal metabolic pathway and suggested a biological role for its metabolites. The complexity of the CYP enzyme system in which different CYPs metabolize arachidonic acid to similar products, share extensive sequence homology and, in many cases, share immunological determinants [1, 5] has complicated functional assignments to individual CYP-epoxygenase isoforms. The epoxygenases expressed in the rat kidney are CYP2C11, 2C23 and 2C24 [6] , and the corresponding enzymes in human kidney are most likely CYP2C8 and CYP2C9 (Table 1 ) [5] . The CYP-epoxygenases expressed in the mouse kidney include CYP2C29, 2C38, 2C39, 2C44 and 2J5 [7, 8] . Nevertheless, it is now widely accepted that members of the CYP2C subfamily, in particular rat CYP2C23 and mouse CYP2C44, are the predominant and functionally relevant kidney epoxygenases [4, 5] . They are mainly responsible for 11,12-EET formation in the kidney [6, 8, 9] . In addition to the CYP2C subfamily, biological roles for the CYP2J epoxygenases are reported [10, 11] . However, the observation that disruption of Cyp2j5 did not affect EET biosynthesis in the kidney suggests the possibility that it may not mainly be responsible for generating EET in the kidney [12] .
Previous studies demonstrating that the kidney expression of CYP2C epoxygenases was dietary salt sensitive [6] , and CYP2C-epoxygenase inhibition caused dietary salt sensitive hypertension [6] , suggested roles for these enzymes in the regulation of renal Na handling. Recent studies with transgenic and/or gene knockout mice provided unique opportunities to characterize the role of specific CYP-epoxygenases in mediating renal Na transport, regulating vasoactivity and maintaining a normal blood pressure. This review aims to summarize results from recent studies and to provide updated views of the potential physiological roles of these enzymes and their EET metabolites.
EPOXYEICOSATRIENOIC ACID INHIBITS EPITHELIAL Na CHANNEL IN THE CORTICAL COLLECTING DUCT
Wei et al. [13] have used the patch-clamp technique in the isolated split-open cortical collecting duct (CCD) to examine the effect of EET on epithelial Na channel (ENaC). Three lines of evidence indicated that CYP-epoxygenase metabolites of arachidonic acid inhibited ENaC [13] . First, application of arachidonic acid inhibited ENaC, and an effect was blocked by N-(methylsulfonyl)-2-(2-propynyl(oxy)-benzehexanamide (MS-PPOH), (an epoxygenase inhibitor) but not by cyclooxygenase or CYP v-hydroxylase inhibitors. Second, the addition of 11,12-EET inhibited ENaC; the effect of 11,12-EET on ENaC was specific because 8,9-EET was KEY POINTS CYP-epoxygenase metabolites inhibit ENaC.
Cyp2c44(À/À) mice are hypertensive by increasing dietary K intake.
CYP-epoxygenase metabolites dilate preglomerular arterioles by activating Ca 2þ -activated big conductance K channels.
EET stimulates the big conductance K channels by activating PP2A. inactive and 14,15-EET had only modest effects on ENaC activity. Moreover, 11R,12S-EET, the major product of the Cyp2c44-dependent arachidonic acid metabolism, was a selective and potent ENaC inhibitor [8, 14] . Third, 11,12-EET was present in the CCD and its level was altered by Na diet [15] . The finding that EET inhibited ENaC was also confirmed in the cultured CCD cell lines (mpkCCD) [16 & ]. Compelling evidence of a role for the CYP-epoxygenase in inhibiting ENaC was obtained from studies using CCDs from Cyp4a10(À/À) mice [9] and showing that although arachidonic acid did not inhibit ENaC activity in these mice, the channel was inhibited by 11,12-EET, and the inhibition of ENaC with amiloride normalized the blood pressures of hypertensive, salt-loaded, Cyp4a10(À/À) mice [9] . Moreover, we have observed that the inhibition of ENaC by adenosine was mediated by the activation of arachidonic acid metabolism by CYP-epoxygenases. Because a high salt intake has been reported to increase adenosine level [17] and renal EET biosynthesis [18] , adenosine may play a role in suppressing Na transport through activating CYP-epoxygenase in the CCD (Fig. 2 ).
EPOXYEICOSATRIENOIC ACID REGULATES K CHANNELS IN THE CORTICAL COLLECTING DUCT
11,12-EET has been shown to inhibit the 18-pS inwardly rectifying K channels, a main type of K channel in the basolateral membrane of CCD [19] . In contrast, 11,12-EET stimulates the Ca 2þ -activated big conductance K channel in the apical membrane of the CCD [18, 19] . Blocking the basolateral K channel by 11,12-EET may be partially responsible for the 11,12-EET-mediated inhibition of Na transport in the CCD because suppression of basolateral K channels depolarizes the cell membrane potential, thereby reducing the driving force for Na entry across the apical membrane (Fig. 2) .
The stimulation of big conductance K channels by 11,12-EET plays a role in mediating flowstimulated and big conductance K channel dependent K secretion [18] . We have observed that inhibition of CYP-epoxygenase activity with MS-PPOH abolished the flow-stimulated and big conductance K channel dependent K secretion. It is well established that big conductance K channels are involved in K secretion in response to a high K intake [20] . Stimulation of big conductance K channels by 11,12-EET is expected to increase the apical K conductance, thereby compensating the effect of decreased driving force for K secretion induced by 11,12-EET-mediated inhibition of ENaC. Therefore, 11,12-EET should play a role in stimulating renal K secretion during a high potassium intake, which increased 11,12-EET formation [14] .
11,12-EPOXYEICOSATRIENOIC ACID DILATES PREGLOMERULAR ARTERIOLES AND ACTIVATES THE BIG CONDUCTANCE K CHANNELS BY STIMULATING PROTEIN PHOSPHATASE 2A
Roles for the EETs in the adenosine A 2A receptor mediated dilation of preglomerular microvessels were proposed on the basis of the observation that inhibition of the CYP-epoxygenases abolished the adenosine effect [21 & ]. Application of a metabolically more stable analogue of 11,12-EET to afferent arterioles induced vasodilation, and the EET analogue effects were blunted by inhibitors of the arteriole smooth muscle big conductance K channel [22] or serine/threonine protein phosphatase 2A (PP2A) [23] . Two additional lines of evidence suggested that the effects of 11,12-EET on Ca 2þactivated big conductance K channels resulted from PP2A stimulation: the 11,12-EET analogue increases PP2A activity; and the addition of PP2A activated big conductance K channels in renal smooth muscles, an effect blocked by okadaic acid. However, the stimulation of the big conductance K channel by 11,12-EET/PP2A may result from removal of a PKA-mediated channel inhibition. It has been shown that the alpha subunit of the big conductance K channel has a splicing isoform containing a 59 amino acid insertion [alternatively spliced stress-regulated exon (STREX)] [24] , and that PKA inhibited the big conductance K channels with STREX insertion. As big conductance K channels in the smooth muscle of afferent arterioles were inhibited by PKA-induced phosphorylation and activated by PP2A-mediated dephosphorylation, it is likely that they expresses STREX splice variants [25 & ]. Hence, 11,12-EET activates the STREX variant of big conductance K and causes afferent arteriole dilation by a PPA2-mediated pathway (Fig. 3 ). 
REGULATION OF EPOXYEICOSATRIENOIC ACIDBIOSYNTHESIS BY DIETARY Na AND K
CYP2C23 and mouse CYP2C44 are the predominant arachidonic acid epoxygenases in rat and mouse kidneys, respectively [6, 9] ; they are upregulated by high Na or K intake [9, 26] and expressed in the CCD. The effect of high K intake on CYP2C44 was specific because the protein level of CYP2J5, which is a rat homolog of human CYP2J2 and expressed in the CCD [27] , was unchanged by increasing dietary K content. Moreover, doubling dietary K from 1% (control) to 2% stimulated, within 7 days, the protein expression of CYP2C23 and CYP2C44 in the rat and mouse kidney, respectively [14,28 && ]. The upregulation of these enzymes by a high K intake was unlikely to result from increases in aldosterone levels, as low Na diets decreased kidney CYP2C23 protein expression while raising plasma aldosterone. In addition, angiotensin II and tumour necrosis factor alpha have been reported to decrease transcription and translation of several CYP epoxygenases including CYP2C44 in the kidney [29, 30] . It was reported that a high salt intake increased renal EET level in Dahl salt-resistant rats, an effect that may be related to stimulation of adenosine A 2A receptor because inhibition of A 2A receptor abolished the high salt intake induced increase in renal EET level [21 & ].
LESSONS LEARN FROM KNOCKOUT AND TRANSGENIC MICE
Transgenic mice provided physiologically relevant information regarding the role of each specific epoxygenase. In the following section, we summarize the main findings obtained from animal models in which each specific epoxygenase was either disrupted or overexpressed.
Cyp2c44(S/S) mice
In these animals, disruption of the Cyp2c44 epoxygenase gene causes hypertension in the animals fed high K (2-10%) diets, whereas wild type mice on similar diets remain normotensive. The finding that arachidonic acid failed to inhibit ENaC in the CCD of Cyp2c44(À/À) mice whereas 11,12-EET was able to block the channel suggests that CYP2C44-derived EETs were responsible for suppressing ENaC activity during increasing dietary K intake, and preventing hypertension, as indicated by the scheme shown in Fig. 4 . High K intake is expected to increase aldosterone and thus stimulates Na vic-dihydroxyeicosatrienoic-K-ATPase and ENaC expression in the aldosterone-sensitive nephron [31] [32] [33] . However, as a high K diet also stimulates protein expression of CYP2C44, the resulting increase in EET levels suppresses Na transport in the collecting duct. Lack of a functional Cyp2c44 gene impairs the balance between aldosterone and EET, thereby increasing Na absorption in the distal nephron. This view was supported by the metabolic cage studies showing that the Cyp2c44(À/À) mice have a diminished ability to excrete Na during increasing K intake, and by the fact that amiloride normalized the blood pressures of high K fed hypertensive Cyp2c44(À/À) mice [22] .
Cyp2j5(S/S) mice
Similar to CYP2C44, CYP2J5 is abundantly expressed in the kidney [12] . However, its role in generating cis-EET in the kidney has been questioned because disruption of the Cyp2j5 gene had no effect on renal EET biosynthesis [12] . Interestingly, female Cyp2j5(À/À) mice had low plasma levels of 17-beta-estradiol. Thus, female, but not male, Cyp2j5(À/À) mice are hypertensive and the mice have an enhanced hypertensive response to angiotensin II and endothelin-1 [12] . As oestrogen replacement normalized the blood pressure and vascular responsiveness to angiotensin II and endothelin, CYP2J5 may play a role in regulating sex hormone rather than EET biosynthesis. Cyp4a10(S/S) and Cyp4a14(S/S) mice CYP4A subfamily proteins are not responsible for converting arachidonic acid to EET. However, disruption of Cyp4a10 impairs the expression of CYP-epoxygenase, suggesting a possible relationship between them. Therefore, we summarize the recent observations obtained from mice with disrupted Cyp4a14 and Cyp4a10, which were hypertensive. Although both mice had the same hypertensive phenotype, the mechanisms causing hypertension were quite different [9, 26] . In both mice models, the disrupted genes are not directly responsible for the hypertension but rather through a mechanism controlling the expression of surrogate prohypertensive or antihypertensive P450 genes. Cyp4a14(À/À) mice showed malespecific hypertension, linked to androgen-mediated increases in renal CYP4A12 protein levels, prohypertensive 20-HETE biosynthesis and renal vascular resistance [26] . In contrast, male and female Cyp4a10(À/À) mice showed dietary salt sensitive hypertension, and although there was no difference between wild type and knockout mice in kidney 20-HETE biosynthesis [9] , hypertensive Cyp4a10(À/À) mice on high salt showed reductions in Cyp2c44 epoxygenase expression, urinary EETs and DHETs, as well as small decreases in urine volume and Na concentration [9] .
Mice with endothelial overexpression of human CYP2J2 and CYP2C8
Endothelium overexpression of human CYP2J2 or CYP2C8 epoxygenase suppressed the endothelin-1 induced vasoconstriction of afferent arterioles and enhanced the vasodilation induced by acetylcholine [34] . Moreover, overexpression of human CYP2J2 or CYP2C8 ameliorated the angiotensin II/high salt induced glomerular injury [12] .
POLYMORPHISMS OF CYTOCHROME P450 EPOXYGENASE
Human CYP2C8 and CYP2C9 are active arachidonic acid epoxygenases [5] , and CYP2J2 catalyzes arachidonic acid epoxidation and v-1 hydroxylation [35] . Animal studies pointed to CYP2C8, CYP2C9, CYP2J2 and the sEH as candidate genes for studies of the molecular basis of human hypertension. CYP2C8 and CYP2C9 are polymorphic genes [36,37 && ], and four of their variants (2C8 Ã 2, 2C8 Ã 3, 2C9 Ã 2 and 2C9 Ã 3) catalyze arachidonic acid epoxidation at markedly reduced rates [36,37 && ,38]. Studies with white and African-American cohorts failed to identify associations between any of these CYP2C variants and hypertension [36,37 && ,39] ; however, lower CYP2C9 Ã 3 allele frequencies were reported in a subset of hypertensive Chinese women [40] . A CYP2J2 promoter variant (G-50T) with reduced transcriptional activity has been associated with no effect, lower risk or higher risk of hypertension in studies using populations of different ethnicities [36,37 && ,39] . Polymorphisms in sEH, in coding and no-coding regions of the gene, are described, and although associations between several of these variants and the risk of cardiovascular and/ or coronary artery disease are reported [36,37 && ], most studies have failed to document links between most of them and hypertension [36,37 && ].
CONCLUSION
There is now convincing evidence of roles for the CYP arachidonic acid epoxygenases in renal physiology and the regulation of distal Na transport and blood pressure in several animal models, as well as their role as potential contributors to the pathophysiology of subsets of human hypertension. Among the many issues that remain outstanding in this area of research, we include: the characterization of the molecular mechanisms responsible for EET-mediated effects on membrane transport and ion channel activity; the study of signalling mechanisms for EETs, and the characterization of putative membrane bound receptors for these eicosanoids; the identification and molecular characterization of mechanisms that control the expression of CYP2C epoxygenases in an organ/tissue/cellspecific fashion; and the analysis of correlations between human pathophysiological conditions and alterations in genes coding and/or responsible for their expression.
